Advertisement

BACITRACIN OPHTHALMICOINTMENT USPSTERILE | BACITRACIN

15:34 EDT 23rd May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx Only

Each gram of ointment contains 500 units of Bacitracin in a low melting special base containing White Petrolatum and Mineral Oil.

The antibiotic, Bacitracin, exerts a profound action against many gram-positive pathogens, including the common Streptococci and Staphylococci. It is also destructive for certain gram-negative organisms. It is ineffective against fungi.

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by Bacitracin susceptible organisms.

This product should not be used in patients with a history of hypersensitivity to Bacitracin.

Bacitracin ophthalmic ointment should not be used in deep-seated ocular infections or in those that are likely to become systemic. The prolonged use of antibiotic containing preparations may result in overgrowth of nonsusceptible organisms particularly fungi. If new infections develop during treatment appropriate antibiotic or chemotherapy should be instituted.

Bacitracin has such a low incidence of allergenicity that for all practical purposes side reactions are practically non-existent. However, if such reaction should occur, therapy should be discontinued.

The ointment should be applied directly into the conjunctival sac 1 to 3 times daily. In blepharitis all scales and crusts should be carefully removed and the ointment then spread uniformly over the lid margins. Patients should be instructed to take appropriate measures to avoid gross contamination of the ointment when applying the ointment directly to the infected eye.

3.5 g (1/8 Oz) sterile tamper proof tubes, NDC 48102-007-35.

Manufactured for:

Fera Pharmaceuticals, LLC Locust Valley, NY 11560

FPBC00N                   Rev. 08/09

NDC 48102-007-35

Rx only

BACITRACIN OPHTHALMIC OINTMENT USP STERILE

CONTAINS: 500 units of Bacitracin per gram, White Petrolatum, Mineral Oil.

NET WT 3.5 g (1/8 Oz)

USUAL DOSAGE: 3 applications daily. See insert for complete information.

KEEP TIGHTLY CLOSEDSTORE AT ROOM TEMPERATUREKEEP OUT OF REACH OF CHILDREN

See crimp of tube for Lot No. & Exp. Date

IMAGE b2983ec7-5f63-4909-891b-92214d3a637f-02.jpg

NDC 48102-007-35

BACITRACINOPHTHALMIC OINTMENT USP STERILE

Rx only

USUAL DOSAGE: 3 applications daily. See insert for complete information.

WARNING: Keep out of reach of children.

See crimp for Lot No. and Exp. Date

CONTAINS: 500 units of Bacitracin per gram, White Petrolatum, Mineral Oil.

NET WT 3.5 g (1/8 Oz)

KEEP TIGHTLY CLOSEDSTORE AT ROOM TEMPERATURE

IMAGE b2983ec7-5f63-4909-891b-92214d3a637f-03.jpg

Manufacturer

Fera Pharmaceuticals, LLC

Active Ingredients

Source

Drugs and Medications [ 148 Associated Drugs and Medications listed on BioPortfolio]

Bacitracin [Dynarex Corporation]

1162_1163_Bacitracin_Ointment

Bacitracin zinc [Dynarex Corporation]

Bacitracin Zinc Ointment

Bacitracin zinc and polymyxin b sulfate [STAT RX USA LLC]

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment [Akorn, Inc.]

Bacitracin zinc and polymyxin b sulfate [Rebel Distributors Corp.]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP, Sterile

Bacitracin zinc and polymyxin b sulfate ophthalmic ointment usp, sterile [Akorn, Inc.]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP, Sterile

Clinical Trials [ 7 Associated Clinical Trials listed on BioPortfolio]

Clinical Evaluation of Bacitracin

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

Nasospore Stent For Use in Enodscopic Sinus Surgery

The purpose of this study is to evaluate a stenting material called Nasopore. This is a synthetic material approved by FDA for use as a stent in postoperative sinus surgery patients. Thi...

Randomized Controlled Trial Comparing Different Closure Methods for Laparoscopic Port Sites

This study wishes to compare patient satisfaction and cosmesis of two different closure methods of laparoscopic ports. One method uses tissue adhesive (Dermabond) with a deep sub-cutaneou...

Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy

We propose an open, prospective, multi-center Phase III study to evaluate the diagnostic performance and safety of seven new T.R.U.E. Test allergens: Gold sodium thiosulfate, Hydrocortison...

Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery

This study will compare the incidence of post-op infection after sinus surgery using conventional post-op oral antibiotics to the incidence of infection after sinus surgery when a bio-reso...

PubMed Articles [ 26 Associated PubMed Articles listed on BioPortfolio]

Intraoperative anaphylaxis associated with bacitracin irrigation.

Purpose Three cases of severe anaphylactic reactions associated with prophylactic bacitracin irrigation during cardiac procedures are describe. Summary In all three cases, bacitracin irrigation was co...

Bacitracin-conjugated superparamagnetic iron oxide nanoparticles: synthesis, characterization and antibacterial activity.

Bacitracin-conjugated superparamagnetic iron oxide (Fe(3) O(4) ) nanoparticles were prepared by click chemistry and their antibacterial activity was investigated. After functionalization with hydrophi...

Relationship between Endogenous Protein Disulfide Isomerase Family Proteins and Glutenin Macropolymer.

The effects of endogenous protein disulfide isomerase (PDI) family proteins on the properties of gluten proteins in dough during breadmaking were determined using bacitracin, an inhibitor of PDI. Brea...

Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters.

Two-component systems (TCSs) are key regulatory pathways allowing bacteria to adapt their genetic expression to environmental changes. Bacitracin, a cyclic dodecylpeptide antibiotic, binds to undecapr...

The ABC transporter, AnrAB, contributes to the innate resistance of Listeria monocyctogenes to nisin, bacitracin and various beta-lactam antibiotics.

A mariner transposon bank was used to identify loci that contribute to the innate resistance of Listeria monocytogenes to the lantibiotic nisin. In addition to highlighting the importance of a number...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement